Janus provides an end-to-end healthcare revenue cycle management (RCM) software platform that helps health systems and revenue cycle service companies understand, optimize, and automate RCM workflow processes. The platform assesses the current state of a revenue cycle operation, identifies efficiency opportunities, and pinpoints where automation can assist teams. Over the past 12 months Janus completed over 500 million process events and automated over 40 million transactions, delivering significant ROI and cost savings for customers. The company intends to use the growth investment for rapid market expansion, product development, and go-to-market initiatives. Brendan Downing is the founder and CEO and leads the company’s strategic direction. Janus is based in Chicago, Illinois. Janus Health develops an end-to-end revenue cycle automation and decision support platform that studies end-user behavior and uses advanced AI to determine the optimal path for each workflow. The platform automates processes and end-to-end workflows at scale and delivers real-time predictive recommendations to guide human worker performance. Janus targets health systems facing labor shortages, shrinking reimbursements, and rising costs-to-collect by offering actionable insights into people, productivity, and practices. The company says its technology enables managers and executives to optimally allocate and manage resources across the revenue cycle. Janus raised an $8 million Series A capital round led by Ensemble Health Partners in partnership with Caduceus Capital Partners. As part of the investment, Jim Gaffney of Ensemble and Sue Tyler of Caduceus will serve on Janus Health's board of directors.

Total raised

$8M

Funding rounds

2

Latest round

Series A

Latest activity

Dec 2021